More recently, Congress began authorizing HHS and its Office of the National Coordinator for Health IT to fund and regulate electronic prescribing standards, health IT standards, certification, "meaningful use", information exchange and other provisions found in the American Recovery and Reinvestment Act of 2009.
Regulation of Health 2.0?
What many do not know is that FDA likely will play an increasingly important role in regulating health IT. We're reminded of this most immediately by the recent announcement that FDA is holding a public meeting regarding the "Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools." The official announcement appears in the Sept. 21, 2009, Federal Register.
This hearing, set for mid-November 2009, in Washington D.C., is intended to help guide FDA in making policy decisions on how the Internet and social media tools (e.g., blogs, microblogs, podcasts, social networking sites, online communications, video sharing, widgets, and wikis) can be used to promote FDA-regulated medical products -- including human and animal drugs and biologics, and medical devices -- in a truthful, non-misleading, and balanced manner.
Specific questions that will be addressed at the meeting include:
- For what online communications will manufacturers, packers or distributors be held accountable?
- How can manufacturers, packers and distributors fulfill regulatory requirements (e.g., fair balance) in their Internet and social network promotions?
- What parameters should apply to the posting of corrective information on Web sites controlled by third parties?
- When is the use of links appropriate?
October 2, 2009
Source: iHealthBeat
No comments:
Post a Comment